AURA · Aura Biosciences, Inc. · Documents
$6.25
-0.05 (-0.71%)
At close · Oct 30
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$652.82M
Shares
103.70M
Volume · Oct 30
107.36K
Avg daily vol (3M)
856.21K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-04-15 | 2024-04-12 | |
| 8-K | — | 2024-03-27 | — | |
| S-3 | — | 2024-03-27 | — | |
| 10-K | — | 2024-03-27 | 2023-12-31 | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-11-09 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-11-06 | — | |
| 8-K | — | 2023-10-02 | 2023-09-26 | |
| 10-Q | — | 2023-08-09 | 2023-06-30 | |
| 8-K | — | 2023-08-09 | — | |
| 8-K | — | 2023-06-07 | — | |
| 8-K | — | 2023-05-11 | — | |
| 10-Q | — | 2023-05-11 | 2023-03-31 | |
| ARS | — | 2023-04-25 | 2022-12-31 | |
| DEFA14A | — | 2023-04-25 | — | |
| DEF 14A | — | 2023-04-25 | 2023-06-07 | |
| 8-K | — | 2023-04-04 | 2023-04-03 | |
| 8-K | — | 2023-03-15 | — | |
| 10-K | — | 2023-03-15 | 2022-12-31 | |
| 8-K | — | 2023-02-16 | — | |
| 8-K | — | 2023-01-06 | — | |
| 8-K | — | 2022-12-05 | 2022-11-30 | |
| 8-K | — | 2022-11-30 | — | |
| 10-Q | — | 2022-11-10 | 2022-09-30 | |
| 8-K | — | 2022-11-10 | — | |
| S-3 | — | 2022-11-01 | — | |
| 8-K | — | 2022-10-03 | 2022-10-02 | |
| 8-K | — | 2022-09-28 | — | |
| 8-K | — | 2022-08-11 | — | |
| 10-Q | — | 2022-08-11 | 2022-06-30 | |
| 8-K | — | 2022-06-30 | — | |
| 8-K | — | 2022-06-22 | 2022-06-19 | |
| 8-K | — | 2022-06-15 | — | |
| 8-K | — | 2022-05-27 | 2022-05-26 | |
| 8-K | — | 2022-05-18 | 2022-05-16 | |
| 8-K | — | 2022-05-12 | — | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| DEFA14A | — | 2022-04-28 | — | |
| DEF 14A | — | 2022-04-28 | 2022-06-15 | |
| 10-K | — | 2022-03-23 | 2021-12-31 | |
| 8-K | — | 2022-03-23 | — | |
| 8-K | — | 2021-11-24 | — | |
| 10-Q | — | 2021-11-24 | 2021-09-30 | |
| 8-K | — | 2021-11-02 | — | |
| S-1/A | — | 2021-10-25 | — | |
| S-1 | — | 2021-10-08 | — |
Showing 51–97 of 97 filings
Key facts
CIK
1501796
CUSIP
05153U107
13F (30d)
26 filings
26 filers
Visit website
Investor relations